Drug Repositioning Market is Expected to Reach US$ 43.33 Bn by the End of 2031-Teva ...

Retrieved on: 2023-01-02 08:35:27

Tags for this article:

Click the tags to see associated articles and topics

Drug Repositioning Market is Expected to Reach US$ 43.33 Bn by the End of 2031-Teva .... View article details on hiswai:

Excerpt

Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma.

Article found on: www.insurancelatam.com